Anesthesia Management of an Emergent Caesarean Section Case with the History of Central Core Myopathy: Case Report

Year 2013, Volume: 38 Issue: 4, 770 - 773, 01.12.2013

Çağla Bali Pınar Ergenoğlu Şule Akın Anış Arıboğan

Abstract

Central core myopatyhy is a rarely seen hereditary neuromuscular disorder that is involved in congenitally myopathies group. The disease is characterized by muscular weakness, skeleton system deformities, increased malign hyperthermia sensitivity and anesthesia management is critically important. In these patients, prolonged muscular weakness and malign hyperthermia that can complicate the perioperative management are the most critical risks. In this case report, anesthesia management of an electively planned caesarean section patient, taken into emergency surgery that is also previously known to have central core myopathy diagnosis will be shared.

Keywords

Central core myopathy, malignant hyperthermia, anesthesia management

Santral Kor Miyopatisi Olan Bir Olguda Acil Sezaryende Anestezi Yönetimi: Olgu Sunumu

Abstract

Santral kor miyopati; konjenital miyopatiler grubunda yer alan, nadir görülen herediter bir nöromüsküler bozukluktur. Santral kor miyopati; kas güçsüzlüğü, iskelet sistemi deformiteleri ve artmış malign hipertermi duyarlılığı ile karakterize olup bu hastaların anestezi yönetimi ayrı bir önem taşımaktadır. Bu hastalarda perioperatif yönetimi güçleştirebilecek uzamış kas güçsüzlüğü ve malign hipertermi en hayati risklerdir. Bu olgu sunumunda santral kor miyopati hastalığı olduğu bilinen elektif sezaryen ameliyatı planlanan ancak acil cerrahiye alınan genç bir hastadaki anestezi yönetimi paylaşılacaktır.

Keywords

Santral kor miyopati, malign hipertermi, anestezi yönetimi

References

• Jungbluth, H. Central core disease. Orphanet J Rare Dis 2007; 2: 25.
• Klingler, W, Rueffert H, Lehmann-Horn F, Girard T and Hopkins PM. Core myopathies and risk of malignant hyperthermia. Anesth Analg 2009; 109: 1167Rosenberg, H, Davis M, James D, Pollock N and Stowell K. Malignant hyperthermia. Orphanet J Rare Dis 2007; 2: 21.
• Robinson, R, Carpenter D, Shaw MA, Halsall J and Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006; 27: 977-89.
• Hopkins, PM. Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth 2000; 85: 118-28.
• Wappler, F. Anesthesia for patients with a history of malignant hyperthermia. Curr Opin Anaesthesiol 2010; 23: 417-22.
• Hopkins, PM. Malignant hyperthermia: pharmacology of triggering. Br J Anaesth 2011; 107: 48-56.
• Foster, RN and Boothroyd KP. Caesarean section in a complicated case of central core disease. Anaesthesia 2008; 63: 544-7.
• Georgiou, AP and Gatward J. Emergency anaesthesia in central core disease. Br J Anaesth 2008; 100: 567.
• Vanĕk, T and Valenta J. Malignant hyperthermia associated with epidural conduction anesthesia. 1989; 128: 889-91.
• Motegi, Y, Shirai M, Arai M, Kato S, Kawana Y and Goto F. Malignant hyperthermia during epidural anesthesia. J Clin Anesth 1996; 8: 157-60.
• Sheu, CC, Tsai JR and Hung JY. Possible malignant hyperthermia during spinal anaesthesia with tetracaine. Anaesthesia 2007; 62: 200-1.
• Russell, R and Comara S. Regional blocks for delivery in women with scoliosis or previous spinal surgery. Int J Obstet Anesth 2003; 12: 308-10.
• Daley, MD, Rolbin SH, Hew EM, Morningstar BA and Stewart JA. Epidural anesthesia for obstetrics after spinal surgery. Reg Anesth 1990; 15: 280-4.
• Maemura, Y. [Effect of ropivacaine on Ca function of skinned skeletal muscle]. Masui 2002; 51: 19-24.
• Yazışma Adresi / Address for Correspondence: Dr. Çağla Bali, Başkent Üniversitesi Tıp Fakültesi Adana Uygulama ve Araştırma Merkezi Anesteziyoloji ve Reanimasyon AD. Dadaloğlu Mh. 39. Sk. No.6 01250, Yüreğir/ADANA e-mail: [e-mail] geliş tarihi/received :18.02.2013 kabul tarihi/accepted:25.03.2013